KHIDI × TMC STAMPED | U.S. Market Entry Session Series (~March 2027) & Upcoming Live Webinar (11.19.2026)

Korea Health Industry Development Institute (KHIDI), in collaboration with Texas Medical Center (TMC), is hosting the KHIDI × TMC STAMPED Session Series from October 2026 through March 2027 to support Korean biohealth companies exploring opportunities in the U.S. market.

Featuring experts from the TMC ecosystem, the series offers practical insights into U.S. market entry, regulatory strategies, clinical development, healthcare innovation, and commercialization. Selected sessions are available via free online live streaming, providing Korean companies with opportunities to gain firsthand knowledge from U.S. industry professionals.

1. Upcoming Online Session

<From Bench to First-in-Human: Navigating Translational Pitfalls in Biotech>

This session explores key challenges in translating biotechnology research into clinical development, with a focus on de-risking scientific, development, and regulatory strategies before entering the clinic.

• Date: November 18, 2026 (U.S.) / November 19, 2026 (Korea)

• Time: 6:00 PM CST / 9:00 AM KST

• Speaker: Saniya Ali

• Format: Online Only

• Participation: Free (Advance registration required)

Register for the Upcoming Session:https://forms.gle/33CedskEPoFC9onA9

2. Explore the Full Session Series

The KHIDI × TMC STAMPED series runs through March 2027, covering topics ranging from healthcare partnerships and clinical trials to investment, regulatory considerations, and market commercialization.

View the Full Schedule & Register for Available Live Streams:https://7470277.hs-sites.com/en/khidi-events-live-sessions

We encourage Korean biohealth companies interested in U.S. market expansion to take advantage of this opportunity to connect with insights from the TMC innovation ecosystem.